BRIM Biotechnology, Inc. (TPE:6885)
27.70
-0.30 (-1.07%)
At close: Jan 21, 2026
BRIM Biotechnology Revenue
BRIM Biotechnology had revenue of 1.23M TWD in the quarter ending September 30, 2025, with 1,762.12% growth. This brings the company's revenue in the last twelve months to 3.17M, up 1,933.33% year-over-year. In the year 2024, BRIM Biotechnology had annual revenue of 333.00K with 270.00% growth.
Revenue (ttm)
3.17M
Revenue Growth
+1,933.33%
P/S Ratio
1,163.31
Revenue / Employee
99.13K
Employees
32
Market Cap
3.69B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 333.00K | 243.00K | 270.00% |
| Dec 31, 2023 | 90.00K | -436.00K | -82.89% |
| Dec 31, 2022 | 526.00K | 166.00K | 46.11% |
| Dec 31, 2021 | 360.00K | -90.41M | -99.60% |
| Dec 31, 2020 | 90.77M | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.10B |
| Lotus Pharmaceutical | 18.66B |
| PharmaEssentia | 13.82B |
| Center Laboratories | 1.57B |
| Oneness Biotech | 117.33M |
| Polaris Group | 70.83M |
| Lumosa Therapeutics | 42.59M |
| Caliway Biopharmaceuticals | 34.99M |